F, S., Y, M., A, E., O, G., & M, M. (2019). Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG). Dove Medical Press.
Cita Chicago Style (17a ed.)F, Salehzadeh, Mohammadikebar Y, Enteshary A, Ghanbarpour O, y Mirzarahimi M. Infliximab in Treatment of Idiopathic Refractory Childhood Pyoderma Gangrenosum (PG). Dove Medical Press, 2019.
Cita MLA (8a ed.)F, Salehzadeh, et al. Infliximab in Treatment of Idiopathic Refractory Childhood Pyoderma Gangrenosum (PG). Dove Medical Press, 2019.
Precaución: Estas citas no son 100% exactas.